Company
United StatesPublic company, NASDAQ: AQSTAquestive Therapeutics Inc. (NASDAQ: AQST), Warren, NJ – FDA Inspections
Inspection records and compliance data for Aquestive Therapeutics Inc. in Warren, New Jersey. 2 FDA inspections on record, last inspected December 06, 2024. Publicly traded as NASDAQ: AQST.
Company Profile
This profile covers Aquestive Therapeutics Inc. based in Warren, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 7, 2021. Last inspected December 6, 2024.
Most cited issue areas
- Failure to develop written procedures1 inspection
- Interval1 inspection
- Late submission of quarterly safety reports1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 6, 2024 | Not classified | Human Drugs | 1257778 |
| October 7, 2021 | VAI | Human Drugs · Bioresearch Monitoring | 1153918 |
FDA documents
Form 483s (1)
EIRs (1)
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Aquestive Therapeutics Inc.
Stock ticker
AQST
Exchange
NASDAQ
Share price
$3.57
Market cap
$448.7M
Price as of
November 13, 2026
FEI Number
3014137981
Address
30 Technology Dr Ste 2a, Warren, New Jersey 07059, United States
Country
United States
ID: 0af9c6f6-1dab-4856-8cfc-33d5fe99b717